Statement of Changes in Beneficial Ownership (4)
2013年10月26日 - 7:54AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Wulff Peter C
|
2. Issuer Name
and
Ticker or Trading Symbol
PURE BIOSCIENCE, INC.
[
PURE
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
CFO, COO & Secretary
|
(Last)
(First)
(Middle)
1725 GILLESPIE WAY
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/23/2013
|
(Street)
EL CAJON, CA 92020
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
10/23/2013
|
|
A
|
|
1000000
(1)
|
A
|
$0.00
|
1000000
|
D
|
|
Common Stock
|
|
|
|
|
|
|
|
250000
|
I
|
Wulff Services, Inc.
(2)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
These shares represent Restricted Stock Units granted to the Reporting Person. 25% of the Restricted Stock Units will vest on March 15, 2014, an additional 25% of the Restricted Stock Units will vest on March 15, 2015 and the remaining 50% of the Restricted Stock Units will vest on March 15, 2016. Vested shares will be delivered to the Reporting Person on the earlier of (i) six months after each vesting date, (ii) upon the separation of the Reporting Person's service to the Issuer or (iii) upon a change of control.
|
(
2)
|
Mr. Wulff is a principal officer and shareholder of Wulff Services, Inc.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Wulff Peter C
1725 GILLESPIE WAY
EL CAJON, CA 92020
|
|
|
CFO, COO & Secretary
|
|
Signatures
|
/s/ Peter Wulff
|
|
10/25/2013
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
PURE Bioscience (PK) (USOTC:PURE)
過去 株価チャート
から 8 2024 まで 9 2024
PURE Bioscience (PK) (USOTC:PURE)
過去 株価チャート
から 9 2023 まで 9 2024
Real-Time news about PURE Bioscience Inc (PK) (その他OTC): 0 recent articles
その他のPure Bioscience, Inc.ニュース記事